Focuses on the evidence for PCOS pathogenesis in women and underlying molecular gateways enabling its development during hyperandrogenic gestations in animal models. Support the SDG target 3.7.1 Proportion of women of reproductive age (aged 15–49 years) who have their need for family planning satisfied with modern methods.

This chapter advances goals 3 and 5 by examining the current research about sleep and insomnia during pregnancy, as well as considerations for assessment and treatment of insomnia during pregnancy.

Aims to inform how to address cultural, religious, and ethnic diversity in prenatal genetic counseling. The goal of SDG targer 3.2 is to end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‑5 mortality to at least as low as 25 per 1,000 live births

Examines the economic impact of bone metastasis for patients with cancer. Supports SDG 3.4.1 to 3.4 , reduce by one thirdmortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory diseases.

This chapter advances goals 3 and 5 by examining the cosmetic related ecological hazards emphasizing on the overview of microplastic ingredients and plastic packaging of PCCPs which are instigating a mounting environmental concern.

This chapter supports SDGS 3, 5 and 16 by explaining the role of psychological science and research in the training and development of law enforcement, in order to improve responses to cases of intimate partner violence (IPV).

This chapter advances goals 3 and 5 by presenting main findings of a literature review on gender in urban mobility and transport planning and highlighting important gaps in the current framings. It offers a clearer understanding of women's needs, usage and preferences for urban transport systems and how they differ from men.

This chapter advances goals 3 and 5 by examining sex differences in hippocampal neurogenesis and hippocampus-dependent cognition, in both healthy individuals and in those with AD, and how these differences are affected by age, hormones, APOE genotype, and experience.

This chapter advances goals 3 and 5 by examining the biological and social reasons women are disproportionately affected by mental health issues. It advocates for a gender-based approach to mental health programs to help women with the unique set of challenges they face.

This chapter advances goals 3 and 5 by summarizing the evidence from recent multidomain lifestyle intervention trials, and the intervention response observed in men and women. While there have been insightful advancements in the field, many important questions still remain. Considerations for future research and risk reduction initiatives are also highlighted.